Five Arrows invests in Sygnature Discovery pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Community Wellness Announces Partnership with Kentucky Hospital Association
Campbell, California – June 10, 2021 –
Life Science Newswire – Community Wellness, a leading national provider of Remote Patient Monitoring (RPM) services, announced a new partnership with the Kentucky Hospital Association (KHA) and their shared services division, KHA Solutions Group (KHASG).
Through this new partnership, KHA and Community Wellness will work together to identify providers that can benefit from their turnkey, value-based care and reimbursement program. By partnering with Community Wellness, Kentucky providers will have the opportunity to transition care into the home and further improve care coordination by monitoring patients’ vitals in real-time on a daily basis. When a patient’s reading falls outside a “safe” parameter, they are notified, along with their physician, so steps can be taken to avoid a negative event – such as a hospital readmiss
ENPICOM will expand its IGX Platform to enable new liability analyses for antibody discovery workflows‘s-Hertogenbosch, The Netherlands, June 10, 2021 – Life Science Newswire – ENPICOM, an innovative bioinformatics software engineering company, announced the upcoming expansion of the IGX Platform&r.
Dublin, Ireland – 01 June 2021 – Life Science Newswire – COREX Logistics is pleased to announce the establishment of a representative office in Kazakhstan. Its office based in Almaty will serve the needs of international pharma and biotech conducting clinical rese.
Search jobs 05-May-2021 Takara Bio Europe AB and PanCryos Announce Licensing Agreement to Enable Development of Cell-Based Therapy for Diabetes
Göteberg, Sweden May 05, 2021
Life Science Newswire – Takara Bio Europe AB (TBEAB) and PanCryos are pleased to announce that they have reached a licensing agreement surrounding TBEAB’s clinical-grade human embryonic stem (hES) cell lines. PanCryos has established a simplified and effective method to generate stem cell-derived, glucose-responsive beta cells and is one of several customers in TBEAB’s new out-licensing program, which enables industrial partners to use the clinical-grade hES cells to develop and commercialize breakthrough cell therapy products for previously unmet indications. Jacqueline Ameri, CEO of PanCryos said, “We are very hopeful that our extensive scientific and industry expertise, combined with TBEAB’s expertise in clinical-grade hES cell production, will